SCOTT PATRICK BRADY, LCPC, NCC
Mental Health at Millard Ave, Chicago, IL

License number

Illinois 180009100

Personal information

See more information about SCOTT PATRICK BRADY at radaris.com

Name

Address

Phone

Scott Brady, age 57

539 Metropolitan St, Aurora, IL 60502

(630) 740-7855

Scott Brady, age 70

361 Arlington Ln, Grayslake, IL 60030

(309) 333-6664

Scott Brady

37385 N Cremona Ave, Lake Villa, IL 60046

(847) 356-6050

Scott H Brady

211 Surrey Ln, Lake Forest, IL 60045

Scott F Brady

55 S Vail Ave, Arlington Heights, IL 60005

(217) 379-3290

Professional information

See more information about SCOTT PATRICK BRADY at trustoria.com

Tax Analyst At Bp Amoco

Position:

Tax Analyst at BP Amoco

Location:

Greater Chicago Area

Industry:

Oil & Energy

Work:

BP Amoco - Tax Analyst

Trader At Toji Trading L.l.c.

Position:

Trader at Toji Trading L.L.C.

Location:

Greater Chicago Area

Industry:

Capital Markets

Work:

Toji Trading L.L.C. - Trader

Education:

Indiana University Bloomington 1992 - 1996
bachelors, public affairs

Scott Brady - Chicago, IL

Work:

Sam's Club
Customer Service Representative The Abbey Pub - Chicago, IL
Floor Partner Demand Media Studios - Online Company
Copywriter and Copy Editor DePaul University - Chicago, IL
Resident Advisor

Education:

DePaul University - Chicago, IL
Bachelor's in English, Playwriting, Digital Cinema

Trader At Toji Trading L.l.c.

Position:

Trader at Toji Trading L.L.C.

Location:

Greater Chicago Area

Industry:

Capital Markets

Work:

Toji Trading L.L.C. - Trader

Independent Financial Professional

Location:

Greater Chicago Area

Industry:

Accounting

Education:

Harvard University Kennedy School of Government 2007 - 2007
Certificate Program, Leadership The University of Chicago - Booth School of Business 1992 - 1994
MBA, Finance & Marketing Loyola University of Chicago 1981 - 1985
BBA, Accounting

Scott Brady

Location:

Greater Chicago Area

Industry:

Financial Services

Composition And Method For Preventing Or Treating A Tauopathy

US Patent:

2012014, Jun 7, 2012

Filed:

Oct 18, 2010

Appl. No.:

12/906617

Inventors:

SCOTT T. BRADY - CHICAGO IL, US
LESTER I. BINDER - CHICAGO IL, US
GERARDO ANDRES MORFINI - CHICAGO IL, US
NICHOLAS M. KANAAN - GRAND RAPIDS MI, US
Nichole E. LaPointe - Santa Barbara CA, US

Assignee:

THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS - URBANA IL

International Classification:

A61K 38/10, A61P 25/28, C12Q 1/02

US Classification:

514 177, 514 214, 435 29

Abstract:

The present invention is a composition and method for the prevention and treatment of a tauopathy. The composition of the invention includes N-terminal amino acid residues of the tau protein, which have been identified as being involved in toxic activation of a PP1/GSK3 signaling cascade and inhibition of fast axonal transport in human tauopathies.

Compositions And Methods For Treating A Disease Mediated By Soluble Oligomeric Amyloid Beta

US Patent:

2011030, Dec 15, 2011

Filed:

Feb 22, 2010

Appl. No.:

13/202838

Inventors:

Scott Thomas Brady - Chicago IL, US
Gerardo Andres Morfini - Chicago IL, US
Gustavo Pigino - Chicago IL, US

International Classification:

A61K 39/395, A61P 25/28, C12N 5/02

US Classification:

4241461, 435375

Abstract:

The present invention relates to methods for restoring fast axonal transport in a cell affected by oligomeric amyloid beta and for treating an oligomeric amyloid beta-mediated disease such as Alzheimer's disease using a Casein Kinase 2 inhibitor and, in some embodiments, a Glycogen Synthase Kinase 3 inhibitor.

Compositions And Methods For Treating Amyotrophic Lateral Sclerosis

US Patent:

2010022, Sep 9, 2010

Filed:

Mar 4, 2010

Appl. No.:

12/717452

Inventors:

Scott Thomas Brady - Chicago IL, US
Gerardo Andres Morfini - Chicago IL, US

International Classification:

A61K 38/00, C12Q 1/34, C12N 5/00

US Classification:

514 2, 435 18, 435375

Abstract:

The invention relates to methods for preserving fast axonal transport in a cell affected by Amyotrophic Lateral Sclerosis by inhibiting pathogenic superoxide dismutase-induced increases in p38α activity. The present invention also provides methods for identifying agents which inhibit the phosphorylation of the kinesin-1, as well as methods for monitoring treatment of Amyotrophic Lateral Sclerosis based on the phosphorylation of p38a, neurofilament heavy chain subunits, and serines 175 and/or 176 of kinesin-1.

Method For Treating A Synucleinopathy

US Patent:

8618063, Dec 31, 2013

Filed:

Apr 9, 2008

Appl. No.:

12/099947

Inventors:

Scott Thomas Brady - Chicago IL, US
Gerardo Andres Morfini - Chicago IL, US

Assignee:

The Board of Trustees of the University of Illinois - Urbana IL

International Classification:

A61K 38/00, A61K 38/55

US Classification:

514 203, 514 75, 514 135, 514 177

Abstract:

The present invention relates to methods for restoring fast axonal transport in a cell which expresses a pathological synuclein protein and for treating a synucleinopathy using a Protein Kinase C mu or Src-Family Tyrosine Kinase inhibitor.